AZOPT susp opht 3 fl 5 ml

7680552360031 CH-55236 S01EC04 11.09.0.
AZOPT susp opht 3 fl 5 ml
AZOPT susp opht 3 fl 5 ml
AZOPT susp opht 3 fl 5 ml
1 / 3
google

Details

Product number
5523601
CPT
-
Packaging group
3 x 5
Unit
ml
Composition
brinzolamidum 10 mg, dinatrii edetas, natrii chloridum, mannitolum, tyloxapolum, carbomerum 974P, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, benzalkonii chloridum 100 µg, ad suspensionem pro 1 ml.

Articles (1)

Azopt, Augentropfensuspension
Augentropfensuspension
3 x 5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/03/2023
Professional SmPC
Français
21/03/2023
Professional SmPC
Italien
21/03/2023
Patient information leaflet
Allemand
17/03/2023
Patient information leaflet
Français
17/03/2023
Patient information leaflet
Italien
17/03/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
100.0 UG Substance HBESI

Reimbursement information

Public price
CHF 44.05
Specialties list
Yes
Generic
No
SL addition date: 01/07/2000

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
55236
Drug name
Azopt, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01EC04
Authorization status
Z
Dispensation category
B
First authorization
17/12/1999
Authorization expiration date
31/12/9999
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom, okuläre Hypertension

Packaging details

Description (FR)
AZOPT susp opht 3 fl 5 ml
Description (DE)
AZOPT Susp Opht 3 Fl 5 ml
Market launch
17/12/1999
Narcotic (BTM)
No

Other packaging sizes

AZOPT susp opht fl 5 ml
5 ML
View